Canada Life
GH icon

Canada Life’s Guardant Health GH Stock Holding History

Canada Life’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
13,260
+1,123
+9% +$122K ﹤0.01% 1188
2026
Q1 		$1.13M Hold
12,137
– – ﹤0.01% 1336
2025
Q4 		$1.24M Sell
12,137
-18,945
-61% -$1.69M ﹤0.01% 1325
2025
Q3 		$1.93M Sell
31,082
-1,403
-4% -$76.3K ﹤0.01% 1242
2025
Q2 		$1.69M Buy
32,485
+2,421
+8% +$108K ﹤0.01% 1254
2025
Q1 		$1.28M Sell
30,064
-1,979
-6% -$85.4K ﹤0.01% 1354
2024
Q4 		$978K Hold
32,043
– – ﹤0.01% 1472
2024
Q3 		$737K Sell
32,043
-2,062
-6% -$58.4K ﹤0.01% 1594
2024
Q2 		$985K Buy
34,105
+1,268
+4% +$29.5K ﹤0.01% 1510
2024
Q1 		$678K Hold
32,837
– – ﹤0.01% 1605
2023
Q4 		$883K Buy
32,837
+4,852
+17% +$127K ﹤0.01% 1536
2023
Q3 		$829K Buy
27,985
+6,666
+31% +$234K ﹤0.01% 1551
2023
Q2 		$768K Buy
21,319
+2,687
+14% +$77.2K ﹤0.01% 1569
2023
Q1 		$438K Hold
18,632
– – ﹤0.01% 1728
2022
Q4 		$509K Buy
18,632
+6,823
+58% +$312K ﹤0.01% 1714
2022
Q3 		$634K Buy
11,809
+7,444
+171% +$382K ﹤0.01% 1636
2022
Q2 		$176K Hold
4,365
– – ﹤0.01% 1838
2022
Q1 		$307K Sell
4,365
-290
-6% -$19.8K ﹤0.01% 1809
2021
Q4 		$464K Hold
4,655
– – ﹤0.01% 1719
2021
Q3 		$586K Sell
4,655
-207
-4% -$24.6K ﹤0.01% 1696
2021
Q2 		$604K Buy
4,862
+94
+2% +$12.6K ﹤0.01% 1700
2021
Q1 		$722K Sell
4,768
-335
-7% -$50.6K ﹤0.01% 1636
2020
Q4 		$656K Buy
5,103
+1,260
+33% +$145K ﹤0.01% 1673
2020
Q3 		$429K Hold
3,843
– – ﹤0.01% 1709
2020
Q2 		$310K Buy
3,843
+1,281
+50% +$103K ﹤0.01% 1799
2020
Q1 		$180K Hold
2,562
– – ﹤0.01% 1843
2019
Q4 		$199K Hold
2,562
– – ﹤0.01% 1929
2019
Q3 		$164K Buy
2,562
+163
+7% +$14.4K ﹤0.01% 990
2019
Q2 		$207K Buy
+2,399
New +$183K ﹤0.01% 2020

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Canada Life's GH Position: Q2 2026 in Review

Canada Life increased its Guardant Health (GH) stake by 9.3% in Q2 2026, buying an estimated $122K and bringing the position to 13,260 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Canada Life first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Canada Life held 13,260 shares of Guardant Health worth $1.98M as of Q2 2026.
  • Canada Life bought 1,123 Guardant Health shares in Q2 2026, an estimated $122K.
  • Guardant Health made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1188 holding.
  • Canada Life first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.